Relative Intelligence · Managed Health Care

How CVS Health (CVS) compares with the whole market and its popular alternatives
Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on CVS alone. It places CVS (CVS Health Corp.) against 19 popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where CVS stands in the market, and of the alternatives worth a closer look.
Period covered: CVS's full trading record, from October 1986 through September 2026. All returns include reinvested dividends. Data as of October 20, 2026.
Data as of October 20, 2026. Full tables and charts read best on a larger screen.
On this page12 sections
Key findings
- Right nowOver the past 6 months, CVS rose 25.6% against 9.1% for the S&P 500 and 11.2% for the Nasdaq 100. Not every peer went the same way. Over the past 6 months, HUM (Humana) rose 104% and HCA (HCA Healthcare) fell 2.2%. Consistency ↓
- Stock or market?The weakness is CVS's own: it fell 11.4% over the past 3 months while the managed health care ETF IHF (iShares U.S. Healthcare Providers ETF) rose 7.1%. The S&P 500 rose 3.9%. Its managed health care peers did not move as one over the past 3 months: HCA (HCA Healthcare) rose 26.0%, while ALHC (Alignment Healthcare) fell 59.7%.
- Past 1 to 3 yearsCVS lagged its managed health care peers in 2023, then moved up the pack in 2025. CVS has edged past the market, rising 18.5% over the past year against 15.8% for the S&P 500 and 17.9% for the Nasdaq 100. Consistency ↓
- Long termCVS turned $10,000 into $14,700 over the past decade, against $42,100 in the S&P 500. Growth of $10,000 ↓
- In a crashThe Covid crash took 27.3% off CVS, against 33.7% for the S&P 500, and less than managed health care peers such as UNH (UnitedHealth Group, 35.9%). Crash tests ↓
- DiversificationCVS is a real diversifier: a correlation of 0.29 with the S&P 500 over 5 years and 0.31 with the total US market, less closely than 71% of stocks worth at least $300 million. That said, over 10 years, CVS's beta versus the S&P 500 was 0.70: in the S&P 500's rising months it gained 59% as much as the index, and in falling months it lost 1.0 times as much. Market capture ↓
- Better options
- Popular alternatives
- CAH (Cardinal Health), MCK (McKesson) and WMT (Walmart) earned more than CVS with less volatility over the past 5 years. CAH returned 42.1% a year at 24.7% volatility, against 5.3% a year at 30.4%.
- Nearby categories and themes
- ENSG (Ensign Group, health care facilities) earned more than CVS with less volatility over the past 5 years: 19.8% a year at 26.8% volatility, against 5.3% a year at 30.4%.
- Whole market
- 891 of the 3,633 stocks and funds worth at least $500 million earned more than CVS with less volatility over the past 5 years, among them AAPL (Apple), MSFT (Microsoft) and VTI (Vanguard Morningstar Total Stock Market ETF).
How much would $10,000 in CVS have grown?
This chart tracks a hypothetical $10,000 investment in CVS over the past 29 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of CVS over the same span and CVS's popular alternatives, among those that traded for the entire period. A second view covers the past 5 years, the period the better options further down the page are judged on. It shows not only where each investment ended up but also how smooth or uneven the path was.
- $10,000 invested in CVS at the end of September 1997 would have grown to $97,705 by September 2026, less than the $132,907 it would have become in SPY, an S&P 500 fund.
- Six of the eight other investments on the chart ended ahead of CVS, and AMZN finished highest, at $11,484,924.
Choose a period
From the end of September 1997 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 544 of the 1,042 stocks and funds worth at least $500 million that traded the whole period ended ahead of CVS; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- AMZN$11M+114,749% total · +27.5% a year
- COR$574,137+5,641% total · +15.0% a year
- WMT$272,033+2,620% total · +12.1% a year
- MCK$208,304+1,983% total · +11.0% a year
- CI$165,842+1,558% total · +10.2% a year
- SPY (S&P 500)$132,907+1,229% total · +9.3% a year
- CAH$113,257+1,033% total · +8.7% a year
- CVS$97,705+877% total · +8.2% a year
- THC$32,921+229% total · +4.2% a year
- EHC$14,086+40.9% total · +1.2% a year
From the end of September 2021 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 2,153 of the 3,628 stocks and funds worth at least $500 million that traded the whole period ended ahead of CVS; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- CAH$49,682+397% total · +37.8% a year
- MCK$43,941+339% total · +34.5% a year
- THC$38,466+285% total · +30.9% a year
- COR$26,420+164% total · +21.4% a year
- WMT$23,813+138% total · +18.9% a year
- SPY (S&P 500)$19,000+90.0% total · +13.7% a year
- OSCR$17,735+77.4% total · +12.1% a year
- AMZN$15,169+51.7% total · +8.7% a year
- CI$14,904+49.0% total · +8.3% a year
- CVS$11,915+19.1% total · +3.6% a year
CVS at a glance
This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.
- CVS's deepest decline since it began trading in 1986 was 64.0%, from March 2001 to January 2003. It took about two years from the low to climb back to its old high.
- Over 29 full calendar years, CVS's best was 2025, when it returned 84.3%, and its worst was 2001, when it lost 50.4%. It lost money in 11 of those years.
- CVS is 13.8% below its all-time high.
The company
- Market value
- $121B
- Industry
- Medical - Healthcare Plans
- Price history from
- October 1986
Returns
- Past 1 year
- +18.5%total return
- Past 3 years
- +52.5%+15.1% a year
- Past 5 years
- +29.2%+5.3% a year
- Past 10 years
- +47.0%+3.9% a year
- Best calendar year
- +84.3%2025
- Worst calendar year
- −50.4%2001
- Losing years
- 11 of 29full calendar years
Risk
- Volatility
- 30.4%typical yearly swing, 5 years
- Sharpe ratio
- 0.32return per unit of risk, 5 years
- Worst decline ever
- −64.0%Mar 2001 to Jan 2003
- From its all-time high
- −13.8%below the peak
CVS against the whole market
Where CVS ranks among every stock and fund, and what across the market has done better.
How does CVS rank among all stocks?
This section ranks CVS on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how CVS stacks up against its peers, these rankings show where it stands in the market as a whole.
- CVS lands in the broad middle of the market on every measure here. CVS is among the steadier stocks: its price swings rank in the top 27% of the 2,893 stocks worth at least $300 million, where the top is the calmest.
Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.
| Measure | CVS | Rank | Standing |
|---|---|---|---|
| 1-year return | +18.5% | 1,291 of 3,287 | top 39% |
| 3-year return | +52.5% | 1,502 of 3,017 | top 50% |
| 5-year return | +29.2% | 1,347 of 2,893 | top 47% |
| 10-year return | +47.0% | 1,589 of 2,202 | bottom 29% |
| Volatility, 5 years | 30.4% | 771 of 2,893 | top 27% |
| Sharpe ratio, 5 years | 0.32 | 1,473 of 2,893 | bottom 50% |
| Worst decline, past 10 years | −56.8% | 753 of 2,187 | top 34% |
What has beaten CVS on both return and risk?
Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer). CVS sits where the dashed lines cross. Anything in the green box above and to the left earned more than CVS with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.
- 313 stocks and 578 ETFs worth at least $500 million sit in the green region: each earned more than CVS over the past 5 years with smaller price swings. That is 25% of the 3,633 screened.
- Among those with at least half CVS's swings, CAH has the best return for its risk: 42.1% a year at 24.7% volatility, 19% less than CVS's 30.4%, and a Sharpe ratio (return above cash per unit of volatility) of 1.55 against 0.32 for CVS.
- Among CVS's popular alternatives, CAH, MCK and COR are in the region. CAH earned 42.1% a year against 5.3% a year for CVS, at 24.7% volatility, 19% less than CVS's 30.4%.
Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 5 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to CVS; faint dots are 93 more of the 891 in the green region (the strongest, one per fund family). 3,633 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.
- Popular alternatives
- Same and neighboring categories, and shared themes
- The whole market
- Others in the green region
Is there a better investment than CVS?
Investments that beat CVS over the past 5 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.
- Among CVS's popular alternatives, CAH, MCK and WMT earned more than CVS with less volatility over the past 5 years. CAH returned 42.1% a year at 24.7% volatility, against 5.3% a year at 30.4%.
- Looking beyond its popular alternatives, ENSG (health care facilities) earned more than CVS with less volatility over the past 5 years: 19.8% a year at 26.8% volatility, against 5.3% a year at 30.4%.
- Across the whole market, 891 of the 3,633 stocks and funds worth at least $500 million earned more than CVS with less volatility over the past 5 years, among them AAPL, MSFT and VTI.
How this works
The table below lists investments that beat CVS over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks CVS's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than CVS follows the table.
Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 5 years; the worst decline covers the past 10 years. Green marks a better figure than CVS's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× CVS's volatility counts as better.
These figures cover the past 5 years. Green marks a better figure than CVS's.
| Investment | Why it is better | Past 5 years | Downside | Long run | Fit | ||||
|---|---|---|---|---|---|---|---|---|---|
| Annual return?higher is better | Volatility?lower is calmer | Sharpe?return per unit of risk | Worst decline?past 10 years | 10Y returntotal | Corr. with CVS?lower diversifies more | Expenseper year | |||
| +5.3% | 30.4% | 0.32 | −56.8% | +47.0% | 1.00 | — | |||
| +12.7% | 17.1% | 0.79 | −33.7% | +321% | 0.29 | 0.09% | |||
| Popular alternativesbest 6 shownThe investments people most often weigh against CVS. 10 of 19 passed at least one test. | |||||||||
| On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.26 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.20 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +20.8% | 22.6% | 0.96 | −25.7% | +508% | 0.12 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +24.2% | 22.8% | 1.07 | −32.4% | +406% | 0.37 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +9.4% | 28.3% | 0.46 | −42.5% | +176% | 0.58 | — | ||
| Higher return, similar volatility | +14.1% | 30.1% | 0.59 | −54.7% | +513% | 0.21 | — | ||
| Same and neighboring categories, and shared themesbest 5 shownEverything else in Managed Health Care and the categories next to it (Health Care Facilities, Health Care Distribution, Application Software), plus CVS's specific themes. 5 of 38 passed at least one test. | |||||||||
ENSGThe Ensign Group, Inc. · Health Care Facilities | Higher return, lower volatility | +19.8% | 26.8% | 0.81 | −55.5% | +896% | 0.17 | — | |
| Higher return in most periods | −0.1% | 39.6% | 0.19 | −55.7% | +715% | 0.08 | — | ||
PTCPTC Inc. · Application Software | Higher return in most periods | +8.3% | 35.0% | 0.40 | −54.4% | +317% | 0.03 | — | |
GWREGuidewire Software, Inc. · Application Software | Higher return in most periods | +8.6% | 43.2% | 0.41 | −60.8% | +216% | 0.16 | — | |
APPFAppFolio Inc. · Application Software | Higher return in most periods | +11.3% | 44.2% | 0.46 | −55.4% | +1,072% | -0.04 | — | |
| The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 1,504 of 3,576 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.33 | — | ||
| On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +17.3% | 18.2% | 0.97 | −40.0% | +352% | 0.46 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +7.2% | 19.2% | 0.46 | −29.0% | +68.8% | 0.26 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +18.5% | 28.0% | 0.75 | −38.5% | +1,168% | 0.06 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +12.5% | 28.2% | 0.56 | −37.1% | +946% | -0.04 | — | ||
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +19.0% | 32.0% | 0.71 | −44.6% | +752% | 0.07 | — | ||
HYGHiShares Interest Rate Hedged High Yield Bond ETF · Bonds | On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes | +6.6% | 7.1% | 0.94 | −23.9% | +74.5% | 0.18 | 1.12% | |
FLRTPacer Aristotle Pacific Floating Rate High Income ETF · Financials | On the frontierSimilar return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes | +6.0% | 2.3% | 2.55 | −21.0% | +58.0% | 0.11 | 0.60% | |
What these numbers mean for CVS
- Annual return
- CVS returned 5.3% a year over the past 5 years with dividends reinvested, against 12.7% a year for the S&P 500. At that pace, $10,000 became about $12,900. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
- Volatility
- CVS's volatility over the past 5 years was 30.4%, 1.8 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, CVS's return lands within 30.4% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
- Sharpe ratio
- CVS's Sharpe ratio over the past 5 years was 0.32, against 0.79 for the S&P 500, so CVS earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
- Worst decline
- CVS's worst fall from a peak to a low over the past 10 years was 56.8%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 56.8% fall takes a 131% gain. Guide: Market crash risk and tail risk →
- Correlation
- Over the past 5 years, CVS's monthly returns had a correlation of 0.29 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against CVS instead: the lower it is, the more that option would diversify a CVS holding. Guide: Correlation and diversification →
Show all 891 stocks and funds worth at least $500 million that earned more than CVS with less volatility
Out of 3,633 tested over 5 years. The strongest 100 are listed, best first, with funds that hold the same thing listed once.
| # | Investment | Found in | Annual return | Volatility | Sharpe | Worst decline | 10Y return | Corr. with CVS | Expense |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Whole market | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.33 | — | |
| 2 | Whole market | +17.3% | 18.2% | 0.97 | −40.0% | +352% | 0.46 | — | |
| 3 | Whole market | +7.2% | 19.2% | 0.46 | −29.0% | +68.8% | 0.26 | — | |
| 4 | Whole market | +18.5% | 28.0% | 0.75 | −38.5% | +1,168% | 0.06 | — | |
| 5 | Whole market | +12.5% | 28.2% | 0.56 | −37.1% | +946% | -0.04 | — | |
| 6 | Whole market | +26.1% | 23.4% | 1.11 | −45.1% | +603% | 0.43 | — | |
| 7 | Whole market | +12.8% | 22.9% | 0.64 | −36.4% | +429% | 0.27 | — | |
| 8 | DXJWisdomTree Japan Hedged Equity Fund · International Equity | Whole market | +26.6% | 19.1% | 1.34 | −39.1% | +428% | 0.08 | 0.48% |
| 9 | LVHIFranklin International Low Volatility High Dividend Index ETF · International Equity | Whole market | +17.0% | 11.1% | 1.48 | −32.4% | +194% | 0.35 | 0.40% |
| 10 | Whole market | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.38 | — | |
| 11 | Popular alternative | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.26 | — | |
| 12 | Whole market | +21.0% | 23.4% | 0.94 | −42.9% | +242% | 0.35 | — | |
| 13 | Whole market | +16.8% | 26.1% | 0.73 | −42.0% | +374% | 0.32 | — | |
| 14 | Whole market | +16.3% | 24.8% | 0.74 | −43.4% | +241% | 0.10 | — | |
| 15 | Whole market | +12.1% | 13.7% | 0.90 | −36.8% | +235% | 0.51 | 0.03% | |
| 16 | Whole market | +19.6% | 24.9% | 0.85 | −24.9% | +266% | 0.24 | — | |
| 17 | Whole market | +22.8% | 24.9% | 0.95 | −30.5% | +200% | 0.18 | — | |
| 18 | Whole market | +15.8% | 20.0% | 0.84 | −42.0% | +310% | 0.61 | — | |
| 19 | Whole market | +18.4% | 26.0% | 0.78 | −35.1% | +779% | 0.13 | 0.09% | |
| 20 | Whole market | +15.7% | 20.4% | 0.82 | −42.6% | +248% | 0.32 | — | |
| 21 | Whole market | +22.7% | 24.4% | 0.97 | −50.5% | +341% | 0.38 | — | |
| 22 | Whole market | +19.2% | 21.6% | 0.93 | −47.3% | +395% | 0.42 | — | |
| 23 | Whole market | +22.4% | 22.3% | 1.02 | −46.3% | +347% | 0.43 | — | |
| 24 | Whole market | +9.7% | 14.3% | 0.72 | −33.4% | +252% | 0.43 | 0.06% | |
| 25 | Whole market | +13.6% | 21.4% | 0.71 | −51.0% | +295% | 0.51 | — | |
| 26 | Whole market | +26.3% | 24.9% | 1.07 | −41.6% | +654% | 0.27 | — | |
| 27 | Whole market | +12.9% | 19.9% | 0.71 | −46.9% | +187% | 0.44 | — | |
| 28 | Whole market | +21.0% | 26.8% | 0.85 | −50.8% | +694% | 0.34 | — | |
| 29 | Whole market | +17.2% | 24.9% | 0.77 | −30.4% | +285% | 0.39 | — | |
| 30 | Whole market | +9.0% | 22.9% | 0.49 | −40.8% | +320% | 0.19 | — | |
| 31 | Whole market | +12.7% | 27.7% | 0.57 | −50.8% | +309% | 0.21 | — | |
| 32 | Whole market | +19.7% | 23.2% | 0.90 | −48.8% | +292% | 0.24 | — | |
| 33 | Whole market | +17.0% | 26.2% | 0.73 | −41.4% | +356% | 0.33 | — | |
| 34 | Whole market | +15.8% | 24.6% | 0.72 | −30.7% | +576% | 0.28 | — | |
| 35 | Whole market | +8.3% | 23.3% | 0.46 | −40.5% | +446% | 0.35 | — | |
| 36 | Whole market | +14.4% | 22.1% | 0.72 | −42.7% | +481% | 0.29 | — | |
| 37 | Whole market | +10.8% | 21.9% | 0.58 | −41.6% | +160% | 0.22 | — | |
| 38 | CBOECboe Global Markets, Inc. · Capital Markets | Whole market | +21.5% | 25.1% | 0.91 | −43.2% | +463% | 0.09 | — |
| 39 | Whole market | +17.9% | 25.4% | 0.78 | −42.5% | +284% | 0.41 | — | |
| 40 | SDCIUSCF SummerHaven Dynamic Commodity Strategy No K-1 Fund · Bonds | Whole market | +20.6% | 18.4% | 1.12 | −45.7% | — | 0.07 | 0.80% |
| 41 | Whole market | +11.7% | 19.4% | 0.67 | −50.8% | +255% | 0.36 | — | |
| 42 | EFViShares MSCI EAFE Value ETF · International Equity | Whole market | +13.6% | 15.9% | 0.88 | −43.2% | +157% | 0.43 | 0.31% |
| 43 | Whole market | +14.0% | 25.7% | 0.64 | −45.5% | +79.7% | 0.26 | — | |
| 44 | Whole market | +8.4% | 15.3% | 0.60 | −28.4% | +202% | 0.48 | 0.08% | |
| 45 | FNDFSchwab Fundamental International Large Company Index ETF · International Equity | Whole market | +13.6% | 16.3% | 0.87 | −40.2% | +194% | 0.42 | 0.25% |
| 46 | VOEVanguard Morningstar Mid-Cap Value ETF · US Mid-Cap Equity | Whole market | +9.4% | 15.8% | 0.65 | −43.2% | +182% | 0.46 | 0.05% |
| 47 | RSReliance Steel & Aluminum Co. · Metals & Mining | Whole market | +24.8% | 28.1% | 0.93 | −40.8% | +626% | 0.35 | — |
| 48 | AVLVAvantis U.S. Large Cap Value ETF · US Large-Cap Value | Whole market | +14.0% | 16.9% | 0.86 | −19.5% | — | 0.41 | 0.15% |
| 49 | PVALPutnam Focused Large Cap Value ETF · US Large-Cap Value | Whole market | +16.1% | 15.1% | 1.07 | −41.3% | — | 0.46 | 0.56% |
| 50 | HDViShares Core High Dividend ETF · US Dividend Equity | Whole market | +12.9% | 13.0% | 1.00 | −37.0% | +172% | 0.39 | 0.08% |
| 51 | RPRXRoyalty Pharma plc · Pharmaceuticals | Whole market | +13.3% | 23.8% | 0.65 | −49.7% | — | 0.45 | — |
| 52 | AVDVAvantis International Small Cap Value ETF · International Equity | Whole market | +13.9% | 17.4% | 0.84 | −43.0% | — | 0.34 | 0.36% |
| 53 | AVUVAvantis U.S. Small Cap Value ETF · US Small-Cap Equity | Whole market | +10.5% | 22.1% | 0.56 | −49.4% | — | 0.42 | 0.25% |
| 54 | RDVYFirst Trust Rising Dividend Achievers ETF · US Dividend Equity | Whole market | +11.3% | 18.8% | 0.67 | −40.6% | +322% | 0.49 | 0.47% |
| 55 | DGXQuest Diagnostics Incorporated · Medical Diagnostics | Whole market | +12.3% | 22.5% | 0.63 | −36.6% | +243% | 0.32 | — |
| 56 | EMXCiShares MSCI Emerging Markets ex China ETF · Emerging Markets Equity | Whole market | +11.1% | 19.5% | 0.64 | −42.8% | — | 0.35 | 0.25% |
| 57 | AVEMAvantis Emerging Markets Equity ETF · Emerging Markets Equity | Whole market | +9.3% | 19.5% | 0.56 | −36.0% | — | 0.33 | 0.33% |
| 58 | PKGPackaging Corporation of America · Packaging | Whole market | +15.4% | 25.8% | 0.69 | −38.2% | +294% | 0.29 | — |
| 59 | EXPDExpeditors International of Washington, Inc. · Freight & Logistics | Whole market | +12.0% | 27.1% | 0.56 | −35.6% | +349% | 0.32 | — |
| 60 | COWZPacer US Cash Cows 100 ETF · US Large-Cap Value | Whole market | +11.4% | 17.7% | 0.70 | −38.7% | — | 0.35 | 0.49% |
| 61 | Popular alternative | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.20 | — | |
| 62 | RNRRenaissanceRe Holdings Ltd. · Insurance | Whole market | +20.1% | 27.8% | 0.80 | −40.7% | +215% | 0.18 | — |
| 63 | AVUSAvantis U.S. Equity ETF · US Total Market | Whole market | +12.2% | 17.2% | 0.76 | −37.0% | — | 0.38 | 0.15% |
| 64 | RWLInvesco S&P 500 Revenue ETF · US Large-Cap Equity | Whole market | +13.7% | 14.4% | 0.97 | −36.1% | +287% | 0.49 | 0.39% |
| 65 | CIBRFirst Trust Nasdaq Cybersecurity ETF · Cybersecurity | Whole market | +14.1% | 26.1% | 0.64 | −33.9% | +454% | 0.15 | 0.58% |
| 66 | IOOiShares Global 100 ETF · Global Equity | Whole market | +15.7% | 17.2% | 0.94 | −31.4% | +361% | 0.21 | 0.40% |
| 67 | JQUAJPMorgan U.S. Quality Factor ETF · US Quality Equity | Whole market | +13.6% | 15.7% | 0.89 | −32.9% | — | 0.37 | 0.12% |
| 68 | VLUEiShares MSCI USA Value Factor ETF · US Large-Cap Value | Whole market | +15.9% | 18.4% | 0.90 | −39.5% | +286% | 0.50 | 0.15% |
| 69 | AIZAssurant, Inc. · Property & Casualty Insurance | Whole market | +13.3% | 25.3% | 0.62 | −44.6% | +312% | 0.33 | — |
| 70 | BBCAJPMorgan BetaBuilders Canada ETF · International Equity | Whole market | +11.4% | 16.7% | 0.73 | −42.8% | — | 0.42 | 0.19% |
| 71 | SEICSEI Investments Company · Asset Management | Whole market | +12.7% | 22.3% | 0.65 | −51.8% | +168% | 0.25 | — |
| 72 | MSGSMadison Square Garden Sports Corp. · Entertainment | Whole market | +18.4% | 25.6% | 0.79 | −41.6% | +432% | 0.18 | — |
| 73 | VPLVanguard FTSE Pacific ETF · International Equity | Whole market | +9.5% | 18.6% | 0.58 | −33.9% | +141% | 0.39 | 0.07% |
| 74 | WTSWatts Water Technologies, Inc. · Industrial Machinery | Whole market | +15.3% | 28.4% | 0.65 | −44.1% | +539% | 0.32 | — |
| 75 | NEUNewMarket Corporation · Specialty Chemicals | Whole market | +21.0% | 26.8% | 0.85 | −40.7% | +165% | 0.24 | — |
| 76 | AIQGlobal X - Artificial Intelligence & Technology ETF · Artificial Intelligence | Whole market | +14.8% | 26.7% | 0.65 | −44.6% | — | 0.21 | 0.68% |
| 77 | FNDESchwab Fundamental Emerging Markets Large Company Index ETF · Emerging Markets Equity | Whole market | +9.8% | 17.0% | 0.64 | −39.9% | +151% | 0.34 | 0.39% |
| 78 | ACTEnact Holdings Inc. · Insurance | Whole market | +20.5% | 24.3% | 0.89 | −20.2% | — | 0.42 | — |
| 79 | THGThe Hanover Insurance Group, Inc. · Property & Casualty Insurance | Whole market | +14.4% | 22.9% | 0.70 | −40.1% | +291% | 0.39 | — |
| 80 | NHCNational HealthCare Corporation · Medical - Care Facilities | Whole market | +32.0% | 28.5% | 1.12 | −35.3% | +394% | 0.25 | — |
| 81 | PDBCInvesco Optimum Yield Diversified Commodity Strategy No K-1 ETF · Broad Commodities | Whole market | +11.7% | 19.3% | 0.67 | −40.7% | +153% | -0.02 | 0.74% |
| 82 | QYLDGlobal X - Nasdaq 100 Covered Call ETF · Equity Income | Whole market | +8.4% | 15.0% | 0.62 | −24.7% | +156% | 0.10 | 0.60% |
| 83 | FLTWFranklin FTSE Taiwan ETF · Technology | Whole market | +21.8% | 24.3% | 0.94 | −38.0% | — | 0.24 | 0.19% |
| 84 | QTUMDefiance Quantum ETF · Technology | Whole market | +22.8% | 28.1% | 0.87 | −38.5% | — | 0.15 | 0.40% |
| 85 | RSPTInvesco S&P 500 Equal Weight Technology ETF · Technology Equity | Whole market | +16.9% | 25.1% | 0.75 | −33.7% | +572% | 0.26 | 0.40% |
| 86 | MSMMSC Industrial Direct Co., Inc. · Industrial Distribution | Whole market | +13.3% | 25.1% | 0.63 | −48.2% | +184% | 0.52 | — |
| 87 | GCOWPacer Global Cash Cows Dividend ETF · International | Whole market | +14.1% | 13.6% | 1.04 | −37.6% | +168% | 0.35 | 0.60% |
| 88 | GUNRNorthern Trust Morningstar Global Upstream Natural Resources ETF · Natural Resources Equity | Whole market | +10.1% | 18.8% | 0.60 | −43.0% | +173% | 0.33 | 0.47% |
| 89 | Whole market | +23.5% | 18.8% | 1.22 | −75.2% | +350% | 0.37 | — | |
| 90 | IWXiShares Russell Top 200 Value ETF · Broad Market | Whole market | +12.7% | 13.8% | 0.94 | −35.8% | +221% | 0.51 | 0.20% |
| 91 | FTGCFirst Trust Global Tactical Commodity Strategy Fund · Alternatives | Whole market | +12.9% | 15.6% | 0.86 | −35.9% | +139% | 0.03 | 0.98% |
| 92 | OMFLInvesco Russell 1000 Dynamic Multifactor ETF · US Multifactor Equity | Whole market | +9.0% | 16.4% | 0.61 | −33.2% | — | 0.35 | 0.29% |
| 93 | FRDMFreedom 100 Emerging Markets ETF · International | Whole market | +17.3% | 22.8% | 0.82 | −40.5% | — | 0.34 | 0.49% |
| 94 | WTVWisdomTree U.S. Value Fund · Broad Market | Whole market | +13.4% | 17.0% | 0.83 | −42.2% | +303% | 0.41 | 0.12% |
| 95 | BKHBlack Hills Corporation · Diversified Utilities | Whole market | +7.8% | 22.6% | 0.45 | −40.5% | +84.7% | 0.39 | — |
| 96 | NWENorthwestern Energy Group Inc · Electric Utilities | Whole market | +10.3% | 21.6% | 0.57 | −39.3% | +104% | 0.36 | — |
| 97 | FLJPFranklin FTSE Japan ETF · International | Whole market | +9.5% | 18.1% | 0.59 | −32.5% | — | 0.34 | 0.09% |
| 98 | DIVBiShares Core Dividend ETF · Dividend & Income | Whole market | +13.9% | 15.4% | 0.93 | −36.9% | — | 0.49 | 0.05% |
| 99 | FVFirst Trust Dorsey Wright Focus 5 ETF · Broad Market | Whole market | +9.7% | 21.1% | 0.55 | −34.0% | +247% | 0.33 | 0.30% |
| 100 | SCHYSchwab International Dividend Equity ETF · International | Whole market | +9.5% | 13.3% | 0.75 | −24.0% | — | 0.43 | 0.08% |
CVS against its popular alternatives
The investments people most often weigh against CVS, compared period by period and year by year.
How do CVS's risk and return compare with its alternatives?
This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at CVS, which divides the map into what did better or worse on each measure.
- Seven of the 19 popular alternatives, led by CAH, MCK and COR, were both more rewarding and calmer than CVS over the past 5 years, earning a higher annual return with lower volatility.
- Over the past 5 years, CVS returned 5.2% a year, less than the S&P 500's 12.7%, with higher volatility (30.4% against 17.1%).
Green points earned more than CVS with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.
All figures
| Investment | Annual return | Volatility |
|---|---|---|
| CAH Cardinal Health, Inc. | +42.1% | 24.7% |
| MCK McKesson Corporation | +38.7% | 25.0% |
| THC Tenet Healthcare Corporation | +32.9% | 45.1% |
| COR Cencora, Inc. | +24.2% | 22.8% |
| WMT Walmart Inc. | +20.8% | 22.6% |
| EHC Encompass Health Corporation | +18.4% | 26.8% |
| OSCR Oscar Health, Inc. | +15.7% | 80.0% |
| HCA HCA Healthcare, Inc. | +14.1% | 30.1% |
| SPY S&P 500State Street SPDR S&P 500 ETF | +12.7% | 17.1% |
| CI Cigna Corporation | +9.4% | 28.3% |
| AMZN Amazon.com, Inc. | +9.0% | 36.6% |
| CVS This pageCVS Health Corp. | +5.3% | 30.4% |
| ELV Elevance Health Inc. | +2.2% | 29.4% |
| UNH UnitedHealth Group Incorporated | +1.1% | 32.1% |
| CNC Centene Corp. | +0.8% | 40.0% |
| HUM Humana Inc. | −0.3% | 38.5% |
| PRVA Privia Health Group, Inc. | −1.5% | 46.8% |
| MOH Molina Healthcare, Inc. | −5.4% | 40.6% |
| CLOV Clover Health Investments, Corp. | −9.3% | 75.7% |
| ALHC Alignment Healthcare, Inc. | −15.1% | 65.8% |
| AGL Agilon Health, Inc. | −31.3% | 104% |
Has CVS consistently beaten its popular alternatives?
This section compares CVS with the investments people most often weigh against it, checking each one over eight periods from one month to ten years. Counting how often an alternative earned more than CVS helps separate lasting outperformance from a single strong stretch.
- Four of the 19 popular alternatives, led by THC, MCK and CAH, outperformed CVS in at least 3 of 5 short-term and 2 of 3 long-term timeframes.
- THC, MCK and CAH outperformed CVS in every long-term period and in all but one short-term period, the most consistent record in the group.
- CAH, MCK and COR earned more for the risk they took than CVS (a higher Sharpe ratio) and fell less in their worst decline of the past 10 years.
A green cell means the alternative earned more than CVS over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 2 of 3 long-term periods.
| Investment | Periods outperformed | Short term | Long term | Risk · 5 years | Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Volatilitylower is calmer | Sharpehigher is better | Worst declinepast 10 years | Expense | Assets | Overlapsame sectors | ||
| CVS CVS Health Corp. (this page) | — | +8.2% | −11.4% | +25.6% | +21.0% | +18.5% | +52.5% | +29.2% | +47.0% | 30.4% | 0.32 | −56.8% | — | $121B | — |
| THC QualifiedTenet Healthcare Corporation | 4/5 short3/3 longAll-weather | +4.3% | +40.1% | +42.4% | +36.5% | +34.7% | +399% | +315% | +1,058% | 45.1% | 0.86 | −71.7% | — | $22B | — |
| MCK QualifiedMcKesson Corporation | 4/5 short3/3 longAll-weather | +16.2% | +24.0% | +20.2% | +25.5% | +31.3% | +131% | +413% | +586% | 25.0% | 1.44 | −38.1% | — | $120B | — |
| CAH QualifiedCardinal Health, Inc. | 4/5 short3/3 longAll-weather | +14.3% | +14.3% | +22.5% | +26.1% | +65.3% | +191% | +479% | +349% | 24.7% | 1.55 | −46.1% | — | $60B | — |
| OSCR QualifiedOscar Health, Inc. | 4/5 short2/3 long | +7.6% | +13.7% | +105% | +125% | +66.8% | +560% | +107% | — | 80.0% | 0.57 | −94.2% | — | $8.7B | — |
| AMZN Specialty RetailAmazon.com, Inc. | 2/5 short3/3 long | +1.6% | +5.1% | +5.8% | +16.0% | +21.3% | +110% | +53.8% | +548% | 36.6% | 0.42 | −56.1% | — | $2.8T | — |
| HCA Medical - Care FacilitiesHCA Healthcare, Inc. | 2/5 short3/3 long | +9.3% | +26.0% | −2.2% | −0.5% | +8.3% | +97.6% | +93.6% | +513% | 30.1% | 0.59 | −54.7% | — | $101B | — |
| WMT Discount StoresWalmart Inc. | 2/5 short3/3 long | +9.7% | +5.3% | −7.5% | +5.2% | +11.0% | +130% | +158% | +508% | 22.6% | 0.96 | −25.7% | — | $938B | — |
| COR Medical - DistributionCencora, Inc. | 1/5 short3/3 long | +8.5% | +13.1% | +6.7% | +1.9% | +5.7% | +86.5% | +195% | +406% | 22.8% | 1.07 | −32.4% | — | $66B | — |
| EHC Medical - Care FacilitiesEncompass Health Corporation | 1/5 short3/3 long | +0.3% | +8.3% | +14.9% | +15.0% | −2.1% | +97.2% | +133% | +340% | 26.8% | 0.77 | −39.5% | — | $12B | — |
| CI Medical - Healthcare PlansCigna Corporation | 2/5 short2/3 long | +11.7% | +8.6% | +10.8% | +11.7% | +2.2% | +5.9% | +56.7% | +176% | 28.3% | 0.46 | −42.5% | — | $81B | — |
| HUM Medical - Healthcare PlansHumana Inc. | 5/5 short1/3 long | +12.9% | +7.3% | +104% | +62.8% | +52.1% | −15.1% | −1.3% | +166% | 38.5% | 0.19 | −69.9% | — | $51B | — |
| CNC Medical - Healthcare PlansCentene Corp. | 5/5 short1/3 long | +9.0% | +7.6% | +84.9% | +69.6% | +98.9% | −1.5% | +4.0% | +129% | 40.0% | 0.24 | −74.1% | — | $35B | — |
| ELV Medical - Healthcare PlansElevance Health Inc. | 4/5 short1/3 long | +7.5% | +15.7% | +39.0% | +26.1% | +26.8% | +2.0% | +11.7% | +307% | 29.4% | 0.23 | −50.4% | — | $95B | — |
| MOH Medical - Healthcare PlansMolina Healthcare, Inc. | 4/5 short1/3 long | +11.1% | −4.3% | +46.4% | +23.1% | +11.3% | −37.0% | −24.3% | +277% | 40.6% | 0.07 | −70.8% | — | $11B | — |
| UNH Medical - Healthcare PlansUnitedHealth Group Incorporated | 4/5 short1/3 long | +11.0% | +0.1% | +31.2% | +27.1% | +18.1% | −15.3% | +5.5% | +241% | 32.1% | 0.20 | −61.4% | — | $376B | — |
| CLOV Medical - Healthcare PlansClover Health Investments, Corp. | 4/5 short1/3 long | +5.7% | +6.7% | +115% | +99.2% | +64.4% | +385% | −38.8% | — | 75.7% | 0.24 | −97.2% | — | $2.5B | — |
| AGL Medical - Care FacilitiesAgilon Health, Inc. | 3/5 short0/3 long | +4.2% | −24.9% | +224% | +445% | +271% | −81.0% | −84.7% | — | 104% | 0.12 | −99.3% | — | $1.5B | — |
| PRVA Medical - Healthcare Information ServicesPrivia Health Group, Inc. | 1/5 short0/3 long | +17.3% | −12.7% | −4.8% | −2.3% | −13.1% | +0.3% | −7.4% | — | 46.8% | 0.20 | −67.3% | — | $2.9B | — |
| ALHC Medical - Healthcare PlansAlignment Healthcare, Inc. | 0/5 short0/3 long | +2.2% | −59.7% | −60.5% | −57.9% | −51.1% | +19.9% | −55.8% | — | 65.8% | 0.08 | −83.6% | — | $1.8B | — |
How did CVS do year by year?
This table shows each investment's total return in every full calendar year since 1997, along with where CVS ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with CVS and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.
- Among its popular alternatives, HCA came out ahead of CVS most often, in 12 of the 14 years both traded.
- Ranked against its popular alternatives each year, CVS finished in the top quarter in eight of 29 years and in the bottom quarter in five. In 2025, it ranked 1 of 20.
- CVS finished ahead of the S&P 500 in 18 of its 29 full calendar years.
Newest year first. Green marks a year in which the fund came out ahead of CVS; gray means the two finished within a fraction of a point. The rank row places CVS among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.
| Investment | Years ahead of CVS | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVS This pageCVS Health Corp. | — | +84.3% | −40.8% | −12.6% | −7.6% | +54.9% | −5.1% | +17.3% | −7.0% | −5.8% | −17.8% | +2.9% | +36.5% | +50.4% | +20.3% | +19.0% | +9.1% | +13.2% | −27.2% | +29.4% | +17.7% | +17.8% | +25.7% | +45.7% | −14.9% | −50.4% | +51.1% | −27.1% | +72.6% | +55.5% |
| Rank among alternatives | Top quarter in 8 of 29 | 1 of 20 | 18 of 20 | 18 of 20 | 13 of 20 | 3 of 16 | 15 of 15 | 10 of 15 | 12 of 15 | 14 of 15 | 12 of 15 | 10 of 15 | 6 of 15 | 10 of 15 | 7 of 15 | 5 of 14 | 11 of 14 | 11 of 14 | 3 of 14 | 4 of 14 | 3 of 14 | 8 of 14 | 8 of 14 | 3 of 13 | 8 of 13 | 11 of 11 | 9 of 11 | 6 of 11 | 3 of 11 | 3 of 10 |
| SPY S&P 500State Street SPDR S&P 500 ETF | 11 of 29 | +17.7% | +24.9% | +26.2% | −18.2% | +28.7% | +18.3% | +31.2% | −4.6% | +21.7% | +12.0% | +1.2% | +13.5% | +32.3% | +16.0% | +1.9% | +15.1% | +26.4% | −36.8% | +5.1% | +15.9% | +4.8% | +10.7% | +28.2% | −21.6% | −11.7% | −9.8% | +20.4% | +28.7% | +33.5% |
| THC Tenet Healthcare Corporation | 13 of 29 | +57.4% | +67.0% | +54.9% | −40.3% | +105% | +5.0% | +122% | +13.1% | +2.2% | −51.0% | −40.2% | +20.3% | +29.7% | +58.2% | −23.3% | +24.1% | +369% | −77.4% | −27.1% | −9.0% | −30.2% | −31.6% | −2.1% | −58.1% | +32.1% | +89.2% | −10.5% | −20.8% | +51.4% |
| MCK McKesson Corporation | 14 of 29 | +44.5% | +23.7% | +24.1% | +51.8% | +44.2% | +27.1% | +26.7% | −28.4% | +12.0% | −28.3% | −4.5% | +29.3% | +67.7% | +25.6% | +11.8% | +13.8% | +62.9% | −40.4% | +29.7% | −1.2% | +64.9% | −1.4% | +19.9% | −27.2% | +4.9% | +61.2% | −71.3% | +46.9% | +96.3% |
| CAH Cardinal Health, Inc. | 12 of 29 | +76.3% | +19.0% | +34.1% | +54.1% | −0.4% | +10.1% | +18.0% | −24.5% | −12.7% | −17.5% | +12.6% | +23.0% | +66.0% | +3.8% | +8.1% | +21.4% | −4.4% | −39.6% | −9.8% | −5.8% | +18.7% | −4.7% | +3.5% | −8.3% | −2.5% | +108% | −36.8% | +51.7% | +29.1% |
| OSCR Oscar Health, Inc. | 2 of 4 | +6.9% | +46.9% | +272% | −68.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AMZN Amazon.com, Inc. | 18 of 28 | +5.2% | +44.4% | +80.9% | −49.6% | +2.4% | +76.3% | +23.0% | +28.4% | +56.0% | +10.9% | +118% | −22.2% | +59.0% | +45.0% | −3.9% | +33.7% | +163% | −44.7% | +135% | −16.5% | +6.8% | −16.0% | +178% | +74.6% | −30.5% | −79.6% | +42.2% | +968% | — |
| HCA HCA Healthcare, Inc. | 12 of 14 | +56.7% | +11.8% | +13.8% | −5.6% | +57.6% | +11.6% | +20.2% | +43.4% | +18.7% | +9.4% | −7.8% | +53.8% | +58.1% | +70.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WMT Walmart Inc. | 14 of 29 | +24.5% | +74.0% | +12.9% | −0.5% | +1.9% | +23.4% | +30.1% | −3.4% | +46.6% | +16.1% | −26.6% | +11.8% | +18.2% | +17.1% | +13.8% | +3.1% | −2.5% | +20.0% | +4.9% | +0.2% | −10.2% | +0.6% | +5.6% | −11.8% | +8.9% | −22.7% | +70.5% | +107% | +74.6% |
| COR Cencora, Inc. | 14 of 29 | +51.5% | +10.4% | +25.3% | +26.3% | +38.0% | +17.0% | +18.2% | −16.6% | +20.6% | −23.3% | +16.9% | +29.9% | +65.3% | +17.9% | +10.3% | +32.4% | +48.0% | −19.8% | +3.3% | +8.9% | +41.4% | +2.5% | +5.6% | −14.5% | +25.8% | +233% | −53.3% | +11.7% | +20.8% |
| EHC Encompass Health Corporation | 13 of 29 | +15.7% | +39.2% | +12.6% | +17.1% | −19.9% | +21.4% | +14.3% | +26.9% | +22.4% | +21.3% | −7.5% | +17.9% | +59.6% | +19.5% | −14.7% | +10.4% | +71.3% | −47.8% | −7.3% | −7.5% | −22.0% | +36.9% | +9.3% | −71.7% | −9.1% | +204% | −65.2% | −44.4% | +43.7% |
| CI Cigna Corporation | 16 of 29 | +1.7% | −6.3% | −8.0% | +46.7% | +12.3% | +1.8% | +7.7% | −6.5% | +52.3% | −8.8% | +42.2% | +17.7% | +63.8% | +27.4% | +14.6% | +4.1% | +110% | −68.6% | +22.6% | +17.9% | +37.1% | +42.8% | +43.6% | −54.8% | −29.0% | +66.6% | +5.7% | +36.9% | +28.5% |
| HUM Humana Inc. | 19 of 29 | +2.4% | −44.0% | −9.9% | +11.2% | +13.8% | +12.7% | +28.9% | +16.3% | +22.6% | +14.9% | +25.1% | +40.4% | +52.3% | −20.6% | +61.5% | +24.7% | +17.7% | −50.5% | +36.2% | +1.8% | +83.0% | +29.9% | +128% | −15.2% | −22.7% | +86.3% | −54.0% | −14.2% | +9.2% |
| CNC Centene Corp. | 13 of 24 | −32.1% | −18.4% | −9.5% | −0.5% | +37.3% | −4.5% | +9.0% | +14.3% | +78.5% | −14.1% | +26.7% | +76.1% | +43.8% | +3.5% | +56.1% | +19.9% | +7.3% | −28.1% | +11.7% | −6.5% | −7.3% | +103% | +25.0% | +53.0% | — | — | — | — | — |
| ELV Elevance Health Inc. | 14 of 24 | −3.1% | −20.7% | −6.9% | +11.8% | +46.1% | +7.8% | +16.3% | +18.1% | +58.7% | +5.1% | +12.9% | +38.2% | +54.6% | −6.3% | +18.2% | −2.4% | +38.4% | −52.0% | +11.5% | −1.4% | +38.8% | +53.3% | +19.3% | +27.1% | — | — | — | — | — |
| MOH Molina Healthcare, Inc. | 15 of 22 | −40.4% | −19.4% | +9.4% | +3.8% | +49.6% | +56.7% | +16.8% | +51.6% | +41.3% | −9.8% | +12.3% | +54.0% | +28.4% | +21.2% | +20.3% | +21.8% | +29.9% | −54.5% | +19.1% | +22.0% | −42.6% | +83.8% | — | — | — | — | — | — | — |
| UNH UnitedHealth Group Incorporated | 18 of 29 | −33.1% | −2.4% | +0.8% | +6.9% | +45.2% | +21.3% | +20.0% | +14.5% | +39.8% | +38.4% | +18.3% | +36.5% | +41.0% | +8.6% | +42.2% | +19.9% | +14.8% | −54.3% | +8.3% | −13.5% | +41.2% | +51.4% | +39.4% | +18.1% | +15.3% | +131% | +23.5% | −13.4% | +10.3% |
| CLOV Clover Health Investments, Corp. | 2 of 5 | −25.4% | +231% | +2.4% | −75.0% | −77.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AGL Agilon Health, Inc. | 0 of 4 | −63.7% | −84.9% | −22.2% | −40.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PRVA Privia Health Group, Inc. | 2 of 4 | +21.3% | −15.1% | +1.4% | −12.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ALHC Alignment Healthcare, Inc. | 1 of 4 | +75.6% | +30.7% | −26.8% | −16.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Risk and diversification
How CVS has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.
What were CVS's worst declines?
A drawdown is the decline from a peak to the lowest point before a new high. This section presents CVS's five deepest drawdowns since it began trading in 1986, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.
- In four of CVS's five worst declines, the S&P 500 held up better over the same dates.
- Not every decline was the market's doing: CVS fell 56.8% from February 2022 to December 2024, while the S&P 500 rose 35.4%.
- The slowest recovery came after CVS fell 45.2% from June 2008 to March 2009; it did not regain that peak until January 2012, three years later.
Green means CVS fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.
| During | CVS fell | S&P 500, same dates | Peak | Low | Time to the low | Back at the peak | Time to recover |
|---|---|---|---|---|---|---|---|
| Dot-com bust | −64.0% | −31.7% | Mar 2001 | Jan 2003 | 22 months | Jul 2005 | 2.5 years |
| 2022 bear market | −56.8% | +35.4% | Feb 2022 | Dec 2024 | 2.8 years | May 2026 | 17 months |
| No named crash | −50.1% | +10.6% | Feb 1999 | Mar 2000 | 13 months | Nov 2000 | 8 months |
| 2015 China and oil sell-off | −50.1% | +46.2% | Jul 2015 | Apr 2019 | 3.8 years | Nov 2021 | 2.6 years |
| 2008 financial crisis | −45.3% | −50.7% | Jun 2008 | Mar 2009 | 9 months | Jan 2012 | 2.8 years |
How did CVS do in stock market crashes?
This section measures how far CVS, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.
- Among its popular alternatives, WMT held up best, falling less than CVS in seven of the ten crashes they both traded through.
- CVS fell further than the S&P 500 in five of the ten crashes it has traded through. The clearest case was the dot-com bust, when CVS fell 62.4% and the S&P 500 fell 47.5%.
Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than CVS.
| Investment | Held up better | 2023 regional bank crisisMar 2023 | 2022 bear marketJan 2022 | Covid crashFeb 2020 | Late-2018 sell-offSep 2018 | February 2018 volatility shockFeb 2018 | 2015 China and oil sell-offAug 2015 | 2011 euro debt crisisJul 2011 | 2010 flash crashMay 2010 | 2008 financial crisisOct 2007 | Dot-com bustMar 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CVS This pageCVS Health Corp. | — | −4.4% | −19.9% | −27.3% | −22.1% | −9.2% | −16.9% | −14.2% | −1.1% | −45.3% | −62.4% |
| SPY S&P 500State Street SPDR S&P 500 ETF | 5 of 10 | −3.4% | −24.5% | −33.7% | −19.3% | −6.5% | −12.8% | −17.9% | −1.5% | −55.2% | −47.5% |
| THC Tenet Healthcare Corporation | 2 of 10 | −10.6% | −45.6% | −67.8% | −42.5% | −3.8% | −57.4% | −42.6% | −4.7% | −86.6% | −20.4% |
| MCK McKesson Corporation | 5 of 10 | −0.9% | −10.5% | −32.1% | −20.7% | −6.5% | −30.8% | −14.2% | −3.5% | −57.7% | −39.4% |
| CAH Cardinal Health, Inc. | 4 of 10 | −3.5% | −21.0% | −32.1% | −25.5% | −4.6% | −15.9% | −17.5% | −1.8% | −57.9% | −36.1% |
| OSCR Oscar Health, Inc. | 0 of 2 | −18.1% | −62.4% | — | — | — | — | — | — | — | — |
| AMZN Amazon.com, Inc. | 3 of 10 | −3.4% | −39.6% | −22.7% | −33.2% | −7.1% | −30.6% | −20.7% | −2.9% | −65.3% | −91.8% |
| HCA HCA Healthcare, Inc. | 3 of 7 | −2.2% | −39.5% | −54.4% | −20.6% | −3.8% | −31.3% | −49.0% | — | — | — |
| WMT Walmart Inc. | 7 of 10 | −0.8% | −25.7% | −13.1% | −18.3% | −4.9% | −22.3% | −10.5% | −1.5% | −26.2% | −31.8% |
| COR Cencora, Inc. | 6 of 10 | −2.3% | −17.8% | −23.8% | −24.2% | −7.1% | −21.4% | −14.5% | −2.8% | −41.9% | −29.7% |
| EHC Encompass Health Corporation | 2 of 10 | −3.1% | −27.3% | −39.5% | −24.1% | −2.7% | −29.9% | −44.2% | −2.6% | −70.0% | −83.5% |
| CI Cigna Corporation | 6 of 10 | −2.6% | −10.7% | −41.3% | −20.8% | −7.4% | −16.2% | −24.0% | −4.7% | −84.3% | −56.3% |
| HUM Humana Inc. | 3 of 10 | −2.0% | −20.9% | −43.4% | −22.8% | −5.1% | −17.3% | −17.5% | −2.7% | −78.4% | −45.3% |
| CNC Centene Corp. | 1 of 9 | −4.1% | −24.1% | −32.4% | −25.7% | −4.2% | −27.4% | −27.5% | −3.3% | −53.1% | — |
| ELV Elevance Health Inc. | 4 of 9 | −2.3% | −15.9% | −42.3% | −15.7% | −3.6% | −22.9% | −23.4% | −0.7% | −67.2% | — |
| MOH Molina Healthcare, Inc. | 1 of 9 | −3.0% | −27.6% | −29.9% | −29.3% | −14.0% | −37.3% | −40.7% | −3.6% | −59.0% | — |
| UNH UnitedHealth Group Incorporated | 6 of 10 | −1.8% | −16.9% | −35.9% | −18.6% | −6.7% | −12.4% | −20.7% | −0.8% | −72.4% | −19.8% |
| CLOV Clover Health Investments, Corp. | 0 of 2 | −6.6% | −59.8% | — | — | — | — | — | — | — | — |
| AGL Agilon Health, Inc. | 0 of 2 | −6.6% | −41.5% | — | — | — | — | — | — | — | — |
| PRVA Privia Health Group, Inc. | 0 of 2 | −8.9% | −34.1% | — | — | — | — | — | — | — | — |
| ALHC Alignment Healthcare, Inc. | 0 of 2 | −11.6% | −51.7% | — | — | — | — | — | — | — | — |
How closely does CVS move with the S&P 500?
Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares CVS with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 10 years.
- 14 of the 14 popular alternatives had a higher capture ratio (upside capture divided by downside capture) than CVS's 0.60, led by MCK, WMT and CAH.
- MCK took just 27% of the S&P 500's losses, against 99% for CVS, while still keeping 72% of its gains.
- Over the past 10 years, CVS captured 59% of the S&P 500's gains in rising months and 99% of its losses in falling months, with a beta of 0.70. Its share of the market's losses was larger than its share of the gains.
Monthly total returns over the past 10 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than CVS's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.
| Investment | Upside capture | Downside capture | Capture ratio | Beta |
|---|---|---|---|---|
| CVS This pageCVS Health Corp. | 59% | 99% | 0.60 | 0.70 |
| MCK McKesson Corporation | 72% | 27% | 2.71 | 0.56 |
| WMT Walmart Inc. | 74% | 36% | 2.08 | 0.53 |
| CAH Cardinal Health, Inc. | 71% | 51% | 1.40 | 0.75 |
| COR Cencora, Inc. | 80% | 58% | 1.39 | 0.56 |
| EHC Encompass Health Corporation | 86% | 71% | 1.22 | 0.92 |
| MOH Molina Healthcare, Inc. | 72% | 63% | 1.14 | 0.74 |
| THC Tenet Healthcare Corporation | 173% | 168% | 1.03 | 1.87 |
| UNH UnitedHealth Group Incorporated | 81% | 82% | 0.98 | 0.70 |
| HCA HCA Healthcare, Inc. | 135% | 140% | 0.97 | 1.37 |
| AMZN Amazon.com, Inc. | 134% | 139% | 0.96 | 1.31 |
| ELV Elevance Health Inc. | 94% | 98% | 0.96 | 0.86 |
| CI Cigna Corporation | 66% | 74% | 0.90 | 0.58 |
| HUM Humana Inc. | 70% | 80% | 0.87 | 0.82 |
| CNC Centene Corp. | 69% | 94% | 0.73 | 0.80 |
What diversifies CVS?
Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with CVS's. Because such investments tend not to fall at the same time, pairing CVS with them can reduce a portfolio's overall swings.
- Moving a fifth of the money in CVS into DXJ would have cut the portfolio's volatility by 19% over the past 5 years and raised its annual return (+3.6% for CVS alone, +8.8% for the mix).
- FIX made money in eight of the 11 calendar years in which CVS lost money.
- Among large ETFs, LVHI, DXJ and EMLP have moved largely independently of CVS over the past 5 years, with correlations of 0.35 or lower, and each still earned a positive 5-year return.
Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 5 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The year columns are the years in which CVS lost money. The last two columns show a portfolio that is 80% CVS and 20% the other investment, rebalanced monthly.
ETFs
| Investment | Correlation | 5Y return | Sharpe | 2024 | 2023 | 2022 | 2020 | 2018 | 2017 | 2016 | 2008 | 2002 | 2001 | 1999 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVS CVS Health Corp. (this page) | 1.00 | +29.2% | 0.32 | −40.8% | −12.6% | −7.6% | −5.1% | −7.0% | −5.8% | −17.8% | −27.2% | −14.9% | −50.4% | −27.1% | 32.0% | +3.6% |
| LVHI InternationalFranklin International Low Volatility High Dividend Index ETF | 0.35 | +119% | 1.48 | +15.9% | +17.4% | +3.8% | −9.0% | −5.2% | +10.0% | — | — | — | — | — | 26.3% | +6.9% |
| DXJ InternationalWisdomTree Japan Hedged Equity Fund | 0.08 | +225% | 1.34 | +29.8% | +42.0% | +6.0% | +3.9% | −19.8% | +22.8% | +1.1% | −20.8% | — | — | — | 25.9% | +8.8% |
| EMLP Broad MarketFirst Trust North American Energy Infrastructure Fund | 0.33 | +101% | 1.04 | +33.4% | +8.0% | +10.4% | −13.4% | −8.7% | +1.1% | +29.8% | — | — | — | — | 26.7% | +6.6% |
| SMH TechnologyVanEck Semiconductor ETF | 0.16 | +323% | 0.97 | +39.1% | +73.4% | −33.5% | +55.5% | −9.1% | +38.5% | +35.6% | −44.7% | −47.0% | −14.6% | — | 27.6% | +11.3% |
| DBEF InternationalXtrackers MSCI EAFE Hedged Equity ETF | 0.37 | +85.0% | 0.96 | +13.4% | +20.1% | −5.1% | +2.1% | −9.5% | +16.7% | +6.3% | — | — | — | — | 26.5% | +6.3% |
| GLD CommoditiesSPDR Gold Shares | 0.10 | +126% | 0.96 | +26.7% | +12.7% | −0.8% | +24.8% | −1.9% | +12.8% | +8.0% | +4.9% | — | — | — | 26.2% | +7.4% |
| SPMO Broad MarketInvesco S&P 500 Momentum ETF | 0.30 | +136% | 0.93 | +45.8% | +17.6% | −10.4% | +28.2% | −0.9% | +27.8% | +7.4% | — | — | — | — | 27.1% | +7.8% |
| XLE EnergyState Street Energy Select Sector SPDR ETF | 0.17 | +177% | 0.93 | +5.6% | −0.6% | +64.4% | −32.7% | −18.2% | −0.9% | +28.0% | −39.0% | −14.8% | −18.2% | +18.1% | 27.0% | +8.4% |
Stocks
| Investment | Correlation | 5Y return | Sharpe | 2024 | 2023 | 2022 | 2020 | 2018 | 2017 | 2016 | 2008 | 2002 | 2001 | 1999 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVS CVS Health Corp. (this page) | 1.00 | +29.2% | 0.32 | −40.8% | −12.6% | −7.6% | −5.1% | −7.0% | −5.8% | −17.8% | −27.2% | −14.9% | −50.4% | −27.1% | 32.0% | +3.6% |
| CAH Medical - DistributionCardinal Health, Inc. | 0.26 | +479% | 1.55 | +19.0% | +34.1% | +54.1% | +10.1% | −24.5% | −12.7% | −17.5% | −39.6% | −8.3% | −2.5% | −36.8% | 27.4% | +10.8% |
| CLS Hardware, Equipment & PartsCelestica Inc. | 0.11 | +3,143% | 1.47 | +215% | +160% | +1.3% | −2.4% | −16.3% | −11.6% | +7.4% | −20.5% | −65.1% | −25.6% | +350% | 29.3% | +23.2% |
| FIX Engineering & ConstructionComfort Systems USA, Inc. | 0.16 | +1,636% | 1.46 | +107% | +79.6% | +17.0% | +6.7% | +0.8% | +32.1% | +18.3% | −15.2% | −9.4% | +73.7% | −58.7% | 28.4% | +19.1% |
| MCK Medical - DistributionMcKesson Corporation | 0.20 | +413% | 1.44 | +23.7% | +24.1% | +51.8% | +27.1% | −28.4% | +12.0% | −28.3% | −40.4% | −27.2% | +4.9% | −71.3% | 27.1% | +10.3% |
| MPC Oil & Gas Refining & MarketingMarathon Petroleum Corporation | 0.16 | +690% | 1.41 | −4.0% | +30.4% | +86.6% | −27.4% | −8.2% | +34.8% | +0.7% | — | — | — | — | 27.4% | +12.8% |
Common questions
What was CVS's worst drawdown?
CVS's deepest decline since it began trading in 1986 was 64.0%, from March 2001 to January 2003. It took about two years from the low to climb back to its old high.
What were CVS's best and worst years?
Over 29 full calendar years, CVS's best year was 2025, when it returned 84.3%. Its worst was 2001, with a return of -50.4%.
Is there a better investment than CVS?
Among CVS's popular alternatives, CAH, MCK and WMT earned more than CVS with less volatility over the past 5 years. CAH returned 42.1% a year at 24.7% volatility, against 5.3% a year at 30.4%. Looking beyond its popular alternatives, ENSG (health care facilities) earned more than CVS with less volatility over the past 5 years: 19.8% a year at 26.8% volatility, against 5.3% a year at 30.4%.
Is CVS more volatile than the S&P 500?
Yes. CVS's volatility over the past 5 years was 30.4%, 1.8 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, CVS's return lands within 30.4% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.
What is CVS's Sharpe ratio?
CVS's Sharpe ratio over the past 5 years was 0.32, against 0.79 for the S&P 500, so CVS earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.
How correlated is CVS with the S&P 500?
Over the past 5 years, CVS's monthly returns had a correlation of 0.29 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against CVS instead: the lower it is, the more that option would diversify a CVS holding.
What are the best alternatives to CVS?
Of the 19 popular alternatives we compared, four outperformed CVS in at least 3 of 5 short-term and 2 of 3 long-term timeframes, with dividends reinvested: THC, MCK and CAH.
Did CVS outperform the S&P 500?
CVS finished ahead of the S&P 500 (SPY) in 18 of 29 full calendar years. In 2025, it returned +84.3%, against +17.7% for the index.
How did CVS do in stock market crashes?
CVS fell less than the S&P 500 (SPY) in four of the ten major crashes it has traded through, and further in five. The clearest case was the dot-com bust, when CVS fell 62.4% and the S&P 500 fell 47.5%.
What diversifies CVS?
These had a low correlation with CVS over the past 5 years and still earned a positive 5-year return: among large ETFs, LVHI (correlation 0.35), DXJ (correlation 0.08) and EMLP (correlation 0.33); among large stocks, CAH (correlation 0.26), CLS (correlation 0.11) and FIX (correlation 0.16). A correlation near zero means the two have moved largely independently.
How we measure
- Short-term periods are 1M, 3M, 6M, YTD, 1Y; long-term periods are 3Y, 5Y, 10Y. An investment outperformed in a period when its total return, with dividends reinvested, was higher than CVS's. Returns within 0.5 points or 3% of CVS's, whichever is larger, count as a tie.
- "Qualified" means outperforming in at least 3 of 5 short-term periods and 2 of 3 long-term periods. "All-weather" means outperforming in every long-term period and all but one short-term period.
- Popular alternatives are the funds and stocks most often compared with this one. We include only those that trade today, are not leveraged or inverse, and hold at least $200 million.
- Volatility is the annualized standard deviation of daily returns over 5 years, a measure of how much the price typically swings in a year. The Sharpe ratio is the return above cash for each unit of that volatility.
- A decline, or drawdown, runs from a peak to the lowest close before the next high. The worst decline ever uses all the price history we have; comparisons between funds use the past 10 years so that younger funds are judged on the same stretch.
- Sector overlap is the share of assets two funds hold in the same sectors. Correlation and the mixed-portfolio figures use monthly returns.
- Upside and downside capture follow Morningstar's definition: the compound monthly return in the months the S&P 500 rose (or fell), divided by the S&P 500's compound return in those months. Beta measures how strongly monthly returns have moved with the S&P 500. All three use the same window for every investment.
- Figures are computed from daily adjusted prices and update after each trading day. Past performance does not predict future results.
More research
Popular alternatives to CVS
MCKMcKesson
CAHCardinal Health
AMZNAmazon.com
HCAHCA Healthcare
WMTWalmart
CORCencora
CICigna
HUMHumana
ELVElevance Health
UNHUnitedHealth Group